🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/12/2023 | 69,37 | 72,03 | 69,30 | 70,23 | +1,49% | 3,94% | 158.600 |
| 18/12/2023 | 67,37 | 71,02 | 67,36 | 69,20 | +2,75% | 5,43% | 195.700 |
| 15/12/2023 | 68,14 | 68,52 | 65,84 | 67,35 | -0,53% | 3,93% | 470.300 |
| 14/12/2023 | 68,09 | 69,74 | 67,34 | 67,71 | +0,64% | 3,52% | 170.800 |
| 13/12/2023 | 63,12 | 67,28 | 62,83 | 67,28 | +6,90% | 7,05% | 125.600 |
| 12/12/2023 | 62,67 | 63,41 | 60,28 | 62,94 | +0,64% | 4,99% | 157.300 |
| 11/12/2023 | 62,00 | 62,78 | 60,80 | 62,54 | +1,16% | 3,19% | 144.600 |
| 08/12/2023 | 61,40 | 62,30 | 60,51 | 61,82 | +0,68% | 2,92% | 101.900 |
| 07/12/2023 | 59,92 | 61,66 | 59,15 | 61,40 | +2,73% | 4,19% | 110.500 |
| 06/12/2023 | 60,11 | 62,25 | 58,97 | 59,77 | +0,27% | 5,46% | 184.900 |
| 05/12/2023 | 59,57 | 60,75 | 59,03 | 59,61 | -0,43% | 2,89% | 159.100 |
| 04/12/2023 | 59,07 | 60,88 | 59,07 | 59,87 | +1,91% | 3,06% | 95.300 |
| 01/12/2023 | 58,18 | 58,99 | 57,14 | 58,75 | +0,75% | 3,18% | 73.800 |
| 30/11/2023 | 58,12 | 58,86 | 57,00 | 58,31 | +1,13% | 3,20% | 68.400 |
| 29/11/2023 | 57,99 | 58,87 | 57,38 | 57,66 | -0,64% | 2,57% | 84.000 |
| 28/11/2023 | 59,30 | 59,79 | 57,72 | 58,03 | -1,66% | 3,49% | 57.700 |
| 27/11/2023 | 59,70 | 60,25 | 59,00 | 59,01 | -1,80% | 2,09% | 90.600 |
| 24/11/2023 | 59,96 | 60,88 | 59,92 | 60,09 | +0,97% | 1,60% | 26.100 |
| 22/11/2023 | 59,14 | 60,10 | 59,10 | 59,51 | +1,76% | 1,69% | 43.400 |
| 21/11/2023 | 58,00 | 58,99 | 57,17 | 58,48 | +0,62% | 3,14% | 102.000 |
| 20/11/2023 | 58,01 | 58,47 | 57,03 | 58,12 | +0,52% | 2,48% | 74.800 |
| 17/11/2023 | 57,74 | 58,35 | 57,28 | 57,82 | +1,21% | 1,85% | 100.600 |
| 16/11/2023 | 56,57 | 57,37 | 55,30 | 57,13 | +1,15% | 3,66% | 92.000 |
| 15/11/2023 | 56,14 | 56,74 | 55,02 | 56,48 | +0,02% | 3,06% | 131.100 |
| 14/11/2023 | 56,50 | 57,41 | 55,48 | 56,47 | +2,36% | 3,42% | 140.300 |
| 13/11/2023 | 55,13 | 56,49 | 55,05 | 55,17 | -0,38% | 2,61% | 140.800 |
| 10/11/2023 | 54,78 | 55,81 | 52,97 | 55,38 | +1,35% | 5,18% | 136.100 |
| 09/11/2023 | 54,99 | 55,50 | 51,21 | 54,64 | +4,61% | 7,80% | 260.500 |
| 08/11/2023 | 53,75 | 54,14 | 51,55 | 52,23 | -1,75% | 4,82% | 89.600 |
| 07/11/2023 | 52,98 | 53,97 | 52,40 | 53,16 | -0,09% | 2,96% | 75.800 |